Key Health Data for the West Midlands 2004
Table 4.2: Health problems affecting 10% or more of clinical follow-up patients
| All tumours (%) | Brain/CNS (%) | Leukaemias (%) | Solid tumours (%) | |
| Obesity, overweight | 16 | 18 | 17 | 14 |
| Thyroxine supplement | 12 | 41 | ||
| Visual handicap | 11 | 38 | 11 | |
| Growth hormone deficiency | 11 | 50 | 10 | |
| Respiratory problems | 11 | 10 | 14 | |
| Nephrectomy | 11 | 22 | ||
| Tissue atrophy | 11 | 20 | ||
| Learning difficulties | 10 | 29 | 11 | |
| Ataxia | 23 | |||
| Epilepsy | 16 | |||
| Precocious puberty | 13 | |||
| Hearing problems | 12 | |||
| Infertility | 10 | |||
| Cardiovascular problems | 10 |
| Key: | ||||
| Thyroxine - Thyroid hormone given to supplement underactive/missing thyroid | ||||
| Nephrectomy - Removal of kidney | ||||
| Tissue atrophy - wasting or under-growth of tissues after irradiation/surgery | ||||
| Ataxia - inability to co-ordinate muscular activity | ||||
| Precocious puberty - early onset of puberty (ie pre-adolescence) | ||||
For more information please contact Sarafina Cotterill on 0121 414 8117
© Department of Public Health and Epidemiology, University of Birmingham